I9DN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arbutus Biopharma Corp

Watchlist Manager

Watchlist

Price: 3.92 EUR 0.26% Market Closed

Market Cap: €739.8m

A	Arbutus Biopharma Corp F:I9DN	US
A	Avila Energy Corp F:6HQ0	CA
C	Cliffside Capital Ltd XTSX:CEP	CA

Profitability Summary

Arbutus Biopharma Corp's profitability score is 46/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

82%

Negative 3Y Average Operating Margin

-567%

Operating Margin is Increasing

-324% > 82%

Exceptional Net Margin

84%

Negative 3Y Average Net Margin

-576%

Net Margin is Increasing

-310% > 84%

Negative Free Cash Flow Margin

-18%

Negative 3Y Average Free Cash Flow Margin

-568%

Free Cash Flow Margin is Increasing

-356% > -18%

Exceptional ROE

95%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-397%

ROIC is Increasing

-171% > 172%

View All

Hide

Collapse

46 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.